Difference between revisions of "Pheochromocytoma"

From WikiAnesthesia
(Created outline)
 
Line 1: Line 1:
{{Infobox comorbidity
{{Infobox comorbidity
| other_names =  
| other_names =  
| anesthetic_relevance =  
| anesthetic_relevance = Critical
| specialty =  
| specialty = Endocrinology
| signs_symptoms =  
| signs_symptoms = Hypertension
| diagnosis =  
Headache
| treatment =  
Diaphoresis
Tachycardia
| diagnosis = Urine metanephrines and catecholamines
Abdominal CT/MRI for localization
| treatment = Surgical resection
Alpha/beta blockade
| image =  
| image =  
| caption =  
| caption =  
}}
}}


Provide a brief summary of this comorbidity here.
'''Pheochromocytoma''' is a rare neuroendocrine disease of the adrenal gland where catecholamine-secreting tumors cause hypertension. Pheochromocytoma is present in 0.05%<ref>{{Cite journal|last=Lo|first=Chung-Yau|last2=Lam|first2=King-Yin|last3=Wat|first3=Ming-Sun|last4=Lam|first4=Karen S.|date=2000-03-01|title=Adrenal pheochromocytoma remains a frequently overlooked diagnosis|url=https://www.americanjournalofsurgery.com/article/S0002-9610(00)00296-8/abstract|journal=The American Journal of Surgery|language=English|volume=179|issue=3|pages=212–215|doi=10.1016/S0002-9610(00)00296-8|issn=0002-9610|pmid=10827323}}</ref> - 0.2%<ref>{{Cite book|last=Yeh|first=Michael|url=https://www.worldcat.org/oclc/1235959889|title=Sabiston textbook of surgery : the biological basis of modern surgical practice|last2=Livhits|first2=Masha|last3=Duh|first3=Quan-Yang|date=2022|publisher=|others=Courtney M., Jr. Townsend, R. Daniel Beauchamp, B. Mark Evers, Kenneth L. Mattox, David C. Sabiston|year=|isbn=978-0-323-64064-0|edition=21st|location=St. Louis, Missour|pages=|chapter=The Adrenal Glands|oclc=1235959889}}</ref> of hypertensive individuals, the incidence of the disease presents equally between men and women with a distribution across age groups but peaks in between 40 and 50 years of age.  The classic presentation of the disease is a triad of symptoms including headache, palpitations, diaphoresis with a documented clinical sign of hypertension (present in 90% of patients with pheochromocytoma)<ref>{{Cite journal|last=Peramunage|first=Dasun|last2=Nikravan|first2=Sara|date=2020-03-01|title=Anesthesia for Endocrine Emergencies|url=https://www.anesthesiology.theclinics.com/article/S1932-2275(19)30088-6/abstract|journal=Anesthesiology Clinics|language=English|volume=38|issue=1|pages=149–163|doi=10.1016/j.anclin.2019.10.006|issn=1932-2275|pmid=32008649}}</ref>. However, patients can often present with less definitive symptoms such as tremor, anxiety, flushing, weight loss, and hyperglycemia. While the majority of pheochromocytoma emerges from adrenal tumors, roughly 15-20% can be extra-adrenal in etiology.


== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==
== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==
Line 39: Line 44:


== References ==
== References ==
 
<references />
[[Category:Comorbidities]]
[[Category:Comorbidities]]

Revision as of 01:53, 9 June 2021

Pheochromocytoma
Anesthetic relevance

Critical

Anesthetic management

{{{anesthetic_management}}}

Specialty

Endocrinology

Signs and symptoms

Hypertension Headache Diaphoresis Tachycardia

Diagnosis

Urine metanephrines and catecholamines Abdominal CT/MRI for localization

Treatment

Surgical resection Alpha/beta blockade

Article quality
Editor rating
Comprehensive
User likes
0

Pheochromocytoma is a rare neuroendocrine disease of the adrenal gland where catecholamine-secreting tumors cause hypertension. Pheochromocytoma is present in 0.05%[1] - 0.2%[2] of hypertensive individuals, the incidence of the disease presents equally between men and women with a distribution across age groups but peaks in between 40 and 50 years of age. The classic presentation of the disease is a triad of symptoms including headache, palpitations, diaphoresis with a documented clinical sign of hypertension (present in 90% of patients with pheochromocytoma)[3]. However, patients can often present with less definitive symptoms such as tremor, anxiety, flushing, weight loss, and hyperglycemia. While the majority of pheochromocytoma emerges from adrenal tumors, roughly 15-20% can be extra-adrenal in etiology.

Anesthetic implications

Preoperative optimization

Intraoperative management

Postoperative management

Related surgical procedures

Pathophysiology

Signs and symptoms

Diagnosis

Treatment

Medication

Surgery

Prognosis

Epidemiology

References

  1. Lo, Chung-Yau; Lam, King-Yin; Wat, Ming-Sun; Lam, Karen S. (2000-03-01). "Adrenal pheochromocytoma remains a frequently overlooked diagnosis". The American Journal of Surgery. 179 (3): 212–215. doi:10.1016/S0002-9610(00)00296-8. ISSN 0002-9610. PMID 10827323.
  2. Yeh, Michael; Livhits, Masha; Duh, Quan-Yang (2022). "The Adrenal Glands". Sabiston textbook of surgery : the biological basis of modern surgical practice. Courtney M., Jr. Townsend, R. Daniel Beauchamp, B. Mark Evers, Kenneth L. Mattox, David C. Sabiston (21st ed.). St. Louis, Missour. ISBN 978-0-323-64064-0. OCLC 1235959889.
  3. Peramunage, Dasun; Nikravan, Sara (2020-03-01). "Anesthesia for Endocrine Emergencies". Anesthesiology Clinics. 38 (1): 149–163. doi:10.1016/j.anclin.2019.10.006. ISSN 1932-2275. PMID 32008649.